Cluster headache: new targets and options for treatment
| Autor: | Joost Haan, Patty G. G. Doesborg |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Severe headache Cluster headache Review Disease treatment targets Disease cluster General Biochemistry Genetics and Molecular Biology 03 medical and health sciences 0302 clinical medicine Quality of life (healthcare) Treatment targets medicine 030212 general & internal medicine General Pharmacology Toxicology and Pharmaceutics Intensive care medicine General Immunology and Microbiology business.industry Calcitonin gene-related peptide targeted therapies Treatment options Articles General Medicine medicine.disease Neuromodulation (medicine) business 030217 neurology & neurosurgery |
| Zdroj: | F1000Research |
| ISSN: | 2046-1402 |
| Popis: | Cluster headache is a severe headache disorder with considerable impact on quality of life. The pathophysiology of the disease remains poorly understood. With few specific targets for treatment, current guidelines mainly include off-label treatment with medication. However, new targets for possible treatment options are emerging. Calcitonin gene-related peptide (CGRP)-targeted medication could become the first (cluster) headache-specific treatment option. Other exciting new treatment options include invasive and non-invasive neuromodulation techniques. Here, we provide a short overview of new targets and treatment options that are being investigated for cluster headache. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|